B-cell chronic lymphocytic leukemia (CLL) had long been recognized as a morpholog-ically
homogeneous disease of mature, resting B lymphocytes. CLL cells arecharacterized by the …

In this review, we summarize the morphological features and immunophenotypic profile of
chronic lymphocytic leukemia (CLL) cells, discuss the value of these investigations as front …

Chronic B-cell leukemias (CLL) are characterised by a striking cytogenetic signature
composed of multiple recurrent chromosomal imbalances involving specific chromosomal …

With great pleasure, we accepted the kind invitation by the editors of The Cancer Journal to
coordinate a special issue on chronic lymphocytic leukemia (CLL). Our interest in CLL goes …

A historical review of gains in the body of knowledge on chronic lymphocytic leukaemia
(CLL) reveals a continuous, steady process from the beginning of the century with the …

Chronic lymphocytic leukemia (CLL) is a lymphoproliferative disease usually involving B-
cells. Characteristically, B-CLL cells express CD5, CD19, CD20, CD23, cCLLa, Fc and …

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world but
is rare in Asia. CLL has a highly varied clinical course. While advances in CLL therapy are …

Abstract chronic lymphocytic leukemia (CLL) is a malignancy of B CD5+ cells and is the
most common type of leukemia in adults. The disease is more common in men over 50 years …

To address the proposition that familial B-cell chronic lymphocytic leukemia (CLL) may
exhibit a more restricted phenotype than sporadic CLL with respect to immunoglobulin gene …

Chronic lymphocytic leukemia (CLL) follows an extremely variable course with survival
ranging from months to decades. Recently, there has been major progress in the …